| [1] |
Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy[J]. J Pediatr，2013，162(3)：477-482.
|
| [2] |
Amin SB, Saluja S, Saili A, et al. Chronic auditory toxicity in late preterm and term infants with significant hyperbilirubinemia[J]. Pediatrics, 2017, 140(4): e20164009.
|
| [3] |
中华医学会儿科学分会新生儿学组，编辑委员会中华儿科杂志. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志，2014，52(10)：745-748.
|
| [4] |
American Academy of Pediatrics Subcommittee on Hyper bilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics，2004，114(1)：297-316.
|
| [5] |
Kumar P, Chawla D, Deorari A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates[J]. Cochrane Database Syst Rev，2011, 12(1)：CD007969.
|
| [6] |
Ebbesen F, Hansen T, Maisels MJ. Update on phototherapy in jaundiced neonates[J]. Curr Pediatr Rev，2017，13(3)：176-180.
|
| [7] |
Sherbiny HS, Youssef DM, Sherbini AS, et al. High-intensity light-emitting diode vs fluorescent tubes for intensive phototherapy in neonates[J]. Paediatr Int Child Health，2016：1-7.
|
| [8] |
Sachdeva M, Murki S, Oleti TP, et al. Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial[J]. Eur J Pediatr, 2015, 174(2): 177-181.
|
| [9] |
张晓蕊，曾超美，刘捷. 强光疗治疗新生儿高胆红素血症的疗效及安全性[J]. 中国当代儿科杂志，2016，18(3)：195-200.
|
| [10] |
Hansen TW. The role of phototherapy in the crash-cart approach to extreme neonatal jaundice[J]. Semin Perinatol，2011，35(3)：171-174.
|
| [11] |
Arnolda G, Thein AA, Trevisanuto D, et al. Evaluation of a simple intervention to reduce exchange transfusion rates among inborn and outborn neonates in Myanmar, comparing pre- and post-intervention rates[J]. BMC Pediatr，2015，15: 216.
|
| [12] |
鲍珊，杨晓燕，唐军，等. 新生儿黄疸研究现状的共词分析[J]. 中国当代儿科杂志，2014，16(8)：820-823.
|
| [13] |
Newman TB, Wickremasinghe AC, Walsh EM, et al. Retrospective cohort study of phototherapy and childhood cancer in northern California[J]. Pediatrics，2016，137(6)：e20151354.
|
| [14] |
Ramy N, Ghany EA, Alsharany W, et al. Jaundice, phototherapy and DNA damage in full-term neonates[J]. J Perinatol，2016，36(2)：132-136.
|
| [15] |
Kahveci H, Dogan H, Karaman A, et al. Phototherapy causes a transient DNA damage in jaundiced newborns[J]. Drug Chem Toxicol，2013，36(1)：88-92.
|
| [16] |
Aspberg S, Dahlquist G, Kahan T, et al. Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma[J]. Pediatr Allergy Immunol，2010，21(4 Pt 2)：e733-e739.
|
| [17] |
Ku MS, Sun HL, Sheu JN, et al. Neonatal jaundice is a risk factor for childhood asthma: a retrospective cohort study[J]. Pediatr Allergy Immunol，2012，23(7)：623-628.
|
| [18] |
Beken S, Aydin B, Zencirogglu A, et al. The effects of phototherapy on eosinophil and eosinophilic cationic protein in newborns with hyperbilirubinemia[J]. Fetal Pediatr Pathol，2014，33(3)：151-156.
|
| [19] |
Aydin B, Beken S, Zenciroglu A, et al. Blood eosinophil levels in newborns with severe indirect hyperbilirubinemia treated with phototherapy[J]. Iran J Pediatr，2014，24(3)：267-272.
|
| [20] |
Arun BT, Bhat BV, Joseph NM. Association between peak serum bilirubin and neurodevelopmental outcomes in term babies with hyperbilirubinemia[J]. Indian J Pediatr，2012，79(2)：202-206.
|
| [21] |
王卫平. 儿科学[M]. 8版. 北京：人民卫生出版社，2013：122-126.
|
| [22] |
Yu C, Li H, Zhang Q, et al. Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011[J]. PLoS One, 2017, 12(6): e179550.
|
| [23] |
Malla T, Singh S, Poudyal P, et al. A prospective study on exchange transfusion in neonatal unconjugated hyperbilirubinemia: in a tertiary care hospital, Nepal[J]. Kathmandu Univ Med J (KUMJ), 2015, 13(50): 102-108.
|
| [24] |
Hakan N, Zenciroglu A, Aydin M, et al. Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey[J]. J Matern Fetal Neonatal Med，2015，28(13)：1537-1541.
|
| [25] |
陈红武，黄为民. 外周动静脉全自动换血术治疗新生儿重度高胆红素血症的临床研究[J]. 南方医科大学学报，2010，30(10)：2396-2398.
|
| [26] |
杨丽莎，郑显兰，何华云，等. 单双倍血量换血治疗新生儿高胆红素血症的效果研究[J]. 重庆医学，2017，46(19)：2618-2620, 2623.
|
| [27] |
Ogunlesi TA, Lesi FE, Oduwole O. Prophylactic intravenous calcium therapy for exchange blood transfusion in the newborn[J]. Cochrane Database Syst Rev，2017，10: CD011048.
|
| [28] |
杨栗茗，苏绍玉，胡艳玲，等. 外周动静脉同步换血疗法治疗新生儿重度高胆红素血症常规补钙的必要性[J/CD]. 中华妇幼临床医学杂志(电子版)，2017，13(6)：692-696.
|
| [29] |
龙丽华，李禄全，余加林，等. 影响换血疗法治疗新生儿高胆红素血症疗效及不良事件发生的多因素分析[J]. 实用儿科临床杂志，2011，26(14)：1096-1098.
|
| [30] |
Wu YW, Kuzniewicz MW, Wickremasinghe AC, et al. Risk for cerebral palsy in infants with total serum bilirubin levels at or above the exchange transfusion threshold: a population-based study[J]. JAMA Pediatr，2015，169(3)：239-246.
|
| [31] |
Wickremasinghe AC, Risley RJ, Kuzniewicz MW, et al. Risk of sensorineural hearing loss and bilirubin exchange transfusion thresholds[J]. Pediatrics, 2015, 136(3): 505-512.
|
| [32] |
Sgro M, Campbell D, Barozzino T, et al. Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia[J]. J Perinatol，2011，31(6)：392-396.
|
| [33] |
Zhuang Y, Li GN, Zhou Y, et al. Relationship of B/A ratio and acidosis with abnormal brainstem auditory evoked potentials in neonates with severe hyperbilirubinemia[J]. Zhongguo Dang Dai Er Ke Za Zhi，2013，15(5)：332-334.
|
| [34] |
Cortey A, Elzaabi M, Waegemans T, et al. Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a Meta-analysis [J]. Arch Pediatr，2014，21(9)：976-983.
|
| [35] |
Louis D, More K, Oberoi S, et al. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and Meta-analysis[J]. Arch Dis Child Fetal Neonatal Ed，2014，99(4)：F325-F331.
|
| [36] |
Ree I, Smits-Wintjens V, van der Bom JG, et al. Neonatal management and outcome in alloimmune hemolytic disease[J]. Expert Rev Hematol，2017，10(7)：607-616.
|
| [37] |
Yang Y, Pan JJ, Zhou XG, et al. The effect of immunoglobulin treatment for hemolysis on the incidence of necrotizing enterocolitis: a Meta-analysis[J]. Eur Rev Med Pharmacol Sci，2016，20(18)：3902-3910.
|
| [38] |
Shahian M, Moslehi MA. Effect of albumin administration prior to exchange transfusion in term neonates with hyperbilirubinemia: a randomized controlled trial[J]. Indian Pediatr，2010，47(3)：241-244.
|
| [39] |
Dash N, Kumar P, Sundaram V, et al. Pre exchange albumin administration in neonates with hyperbilirubinemia: a randomized controlled trial[J]. Indian Pediatr, 2015, 52(9): 763-767.
|
| [40] |
Chen Z, Zhang L, Zeng L, et al. Probiotics supplementation therapy for pathological neonatal jaundice: a systematic review and Meta-analysis[J]. Front Pharmacol，2017，8：432.
|
| [41] |
Demirel G, Celik IH, Erdeve O, et al. Impact of probiotics on the course of indirect hyperbilirubinemia and phototherapy duration in very low birth weight infants[J]. J Matern Fetal Neonatal Med, 2013, 26(2): 215-218.
|
| [42] |
刘备，马国. 新生儿黄疸的治疗药物研究进展[J]. 中国医院药学杂志，2015，35(16)：1515-1519.
|
| [43] |
Zeng J, Wang SJ, Li YM, et al. Yinzhihuang oral liquid in the treatment of neonatal jaundice: a Meta-analysis[J]. Pharm Biol, 2017, 55(1): 554-559.
|
| [44] |
魏伟，刘俐，杨慧. 肠道益生菌联合茵栀黄治疗轻、中度新生儿黄疸疗效分析[J]. 医药前沿，2016, 6(26): 60-61.
|
| [45] |
Wong RJ, Vreman HJ, Schulz S, et al. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins[J]. J Perinatol, 2011, 31 (Suppl 1): S35-S41.
|
| [46] |
Fujioka K, Kalish F, Wong RJ, et al. Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model[J]. Pediatr Res，2016，79(2)：251-257.
|
| [47] |
Bhutani VK, Poland R, Meloy LD, et al. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia[J]. J Perinatol，2016，36(7)：533-539.
|
| [48] |
Kaabneh MA, Salama GS, Shakkoury AG, et al. Phenobarbital and phototherapy combination enhances decline of total serum bilirubin and may decrease the need for blood exchange transfusion in newborns with isoimmune hemolytic disease[J]. Clin Med Insights Pediatr, 2015, 9: 67-72.
|
| [49] |
Sharma D, Farahbakhsh N, Sharma P, et al. Role of oral zinc supplementation for reduction of neonatal hyperbilirubinemia: a systematic review of current evidence[J]. J Matern Fetal Neonatal Med，2017，30(16)：1953-1962.
|
| [50] |
Mishra S, Cheema A, Agarwal R, et al. Oral zinc for the prevention of hyperbilirubinaemia in neonates[J]. Cochrane Database Syst Rev，2015(7): D8432.
|
| [51] |
Mosayebi Z, Rahmani M, Behjati AS, et al. Evaluation of serum zinc levels in hyperbilirubinemic neonates before and after phototherapy[J]. Iran J Pediatr，2016，26(3)：e4146.
|
| [52] |
Kumar P, Adhisivam B, Vishnu BB. Clofibrate as an adjunct to phototherapy for unconjugated hyperbilirubinemia in term neonates[J]. Indian J Pediatr, 2017, 84(10): 763-767.
|
| [53] |
Xiong T, Chen D, Duan Z, et al. Clofibrate for unconjugated hyperbilirubinemia in neonates: a systematic review[J]. Indian Pediatr，2012，49(1): 35-41.
|
| [54] |
Goyal P, Mehta A, Kaur J, et al. Fluid supplementation in management of neonatal hyperbilirubinemia: a randomized controlled trial[J]. J Matern Fetal Neonatal Med，2017：1-7.
|
| [55] |
Lai N M, Ahmad KA, Choo YM, et al. Fluid supplementation for neonatal unconjugated hyperbilirubinaemia[J]. Cochrane Database Syst Rev, 2017, 8: CD011891.
|